Quirino Lai is an expert in Surgery at Policlinico Umberto I (Italy). As of October 2026, ScienceLeadR ranks Quirino Lai in the top 1% of experts worldwide for Liver Transplantation, Tissue Transplantation and Liver Neoplasms. Quirino Lai has authored 391 publications, the most recent in 2026, and is an investigator in 7 clinical trials, 1 of them ongoing. SLR score: 1,361 (community average: 125). How the SLR is computed.

LeadR Profile

Quirino Lai Policlinico Umberto I Italy
1 361 ScienceLeadR Reputation 1361
Network Map

Surgery

Subspecialties: Hepatology - Transplantation - Gastroenterology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2005 - 2026

Source: PubMed

Sapienza University of Rome

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 391

Citations

Citations: 4 749 1st author: 120 Last author: 38 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Rethinking selection criteria for liver transplantation in hepatocellular carcinoma: from morphology to artificial intelligence.
PMID 42891682 — liver transplantation, intelligence, carcinoma, hepatocellular, neoplasms, multiple chronic conditions, liver, machine learning, transplants, therapeutics, artificial intelligence, transplantation
Expert Rev Gastroenterol Hepatol20260
Reply to Dal, Z.; Erkan, M. Comment on "Lai et al. Liver Transplantation for the Cure of Neuroendocrine Liver Metastasis: A Systematic Review with Particular Attention to the Risk Factors of Death and Recurrence. Biomedicines 2024, 12, 2419".
PMID 42792851 — liver transplantation, liver, neoplasm metastasis, risk factors, transplantation
Biomedicines20260
Liver Transplant Outcomes in Patients With Transjugular Intrahepatic Portosystemic Shunt: A Retrospective Cohort Study With Propensity Score Analysis.
PMID 42306237 — hypertension, liver transplantation, stents, mortality, cohort studies, propensity score, hospital mortality, liver, portasystemic shunt, surgical, hypertension, portal, transplants, intensive care units, transplantation, postoperative complications, ascites
J Clin Exp Hepatol20260
From Risk to Balance: A Novel Approach Integrating Donor, Recipient, and Procedural Factors to Predict 12-Month Graft Loss in Liver Transplantation.
PMID 42279013 — liver transplantation, liver, transplants, transplantation
J Clin Med20260
Direct Acting Antivirals Before Surgical Resection of HCV Related HCC: Impact on Tumour Pathology and Outcomes.
PMID 42261242 — carcinoma, hepatocellular, pathology, liver, therapeutics, antiviral agents
Liver Int20260

Clinical Studies 7

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 7

By status:

Completed 5
Recruiting 1
Unknown 1

By type:

Observational 6
Interventional 1

By Monocentric/Multicentric:

monocentric 5
multicentric2to4 1
multicentric5to9 0
multicentricup10 1

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Indocyanine Green Clearance Test in Liver Transplantation (LivInG)
NCT05228587 — liver diseases, injections, liver transplantation, digestive system diseases, neoplasms, recycling, liver, reperfusion, reperfusion injury, transplants, digestive system, indocyanine green, ischemia, transplantation
N/ARecruiting2022

LeadR Networks

Main global connection map